# After $10.9B exit to AbbVie, Apogee execs join Paragon to scale its R&D, company creation engine

> **Open Intelligence Dossier** · First detected: 2026-10-13 17:00 UTC · Category: Business

## Executive Summary
Former Apogee executives join Paragon Labs to scale R&D following an acquisition, while Alaunos Therapeutics secures major financing.

## Intelligence Brief
According to coverage from outlets including Endpoints News, Fierce Biotech, PR Newswire, Investing.com, and BioPharma Dive, former executives from Apogee have joined Paragon Labs to scale its research and development and company creation engine. This leadership expansion follows a high-profile exit involving Apogee. Simultaneously, related activity in the biotechnology sector features Alaunos Therapeutics, which announced that it expects to receive nearly 350 million dollars in funding through a private placement. Coverage does not yet specify all terms of the executive transition beyond the stated movement of personnel into Paragon Labs.


Additional reporting from platforms such as Dealroom, Marketscreener, TipRanks, Quiver Quantitative, and Investorideas.com emphasizes that Alaunos Therapeutics has acquired Velaris Therapeutics alongside securing its major financing package led by Fairmount. Market activity surged as a result of these developments. Outlets including Yahoo Finance, Benzinga, Finimize, StocksToTrade, and Timothy Sykes tracked significant stock movement, with Alaunos Therapeutics experiencing triple-digit gains, high volume, and intense volatility that caught the attention of pre-market and midday traders. The broader context provided by the headlines reflects high activity across several small-cap and health care equities.


Kalkine.ca and Investing.com Canada noted market positioning involving multiple entities, such as JBDI Holdings, Picard Medical, and NetApp, highlighting how technical indicators like the Relative Strength Index placed certain equities on pre-market watchlists. The intersection of major biotech acquisitions, massive private placements, and executive team realignments creates a complex backdrop of financial movement and corporate restructuring across the sector. Coverage does not yet specify the full long-term operational pipeline for Paragon Labs under its new leadership team, nor does it detail the exact closing timeline for the Alaunos Therapeutics private placement. Observers and market participants are closely monitoring subsequent trading sessions for sustained volume in stocks like TCRT, as well as tracking further spinouts and reverse mergers emerging from company creation engines like Paragon as the business quarter progresses.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| kalkine.ca | Which of Alaunos Therapeutics (NASDAQ:TCRT), JBDI Holdings (NASDAQ:JBDI), Picard Medical (NYSEAMERICAN:PMI) or NetApp (NASDAQ:NTAP) Is the Most Overbought Name on Wednesday's Pre-Market List, With an RSI Above 75? | [Source Link](https://news.google.com/rss/articles/CBMizAJBVV95cUxOaHJTcWpsMVU5YUFmREtQMDBDN1RUbG5ZMTY5SUJVa1lYS0FjMzBtb2RlUmdmQlFTc1lOZjNHZ05ENFNzLUxMaGRLVWZFRklkLV9FZ2RMalpfWnVNSDVTOTRORFllNFB4R0dkenIyTTlHUnNKVDFObEQzZXFuUEx6YWVyQkE0US05UE5pUzdBbHJLUW0zVzBrR0dRaDJFUTA0NnNIRS1oS1RfNXhXQlFOZkE5VGRyRlh2bGhqSk55WUJCeDdIMG5yODdudTlQUVNJRkdFTzdxbDNEcm5YR05oVi1PNF9FbS14aGJWbEVoeTVnLXZvWkoxS2k1d2dxa3dEVl9mTGM5X2NZdEVJbzNkb2JJNHVhRHhrRVVBbWZtSjRlYVFUbjg3MEVfSEJlMDhJWnp4SXIxYkNGUXdEYzhLa0hvMXhfVUV5T0gzSg?oc=5) |
| BioPharma Dive | Another Paragon spinout goes public through reverse merger | [Source Link](https://news.google.com/rss/articles/CBMipgFBVV95cUxNNjJwX3M1U3AxY2xPcnlvTW1zV0hzNlBXWkhBU0RNY0JSN2QweTgxZ2l6ck5XSUY0eW1jdDUxeFBvdHE3U2pIUi1fMnJHd202aGdIT3lmcTlLUXBSbmtULUdHbHlUZDREQ2R0dC1TRHZWVWtmMEY5VEhId012dHg5dnRtdTlqVDB1MzFMaDR5Mmk4QmFhVEV0ckI3ekxHVjdyZTJxNkVn?oc=5) |
| Dealroom | Alaunos Therapeutics lands $350M private placement led by Fairmount | [Source Link](https://news.google.com/rss/articles/CBMiogFBVV95cUxQb3M0RV9XTmpBQzNrOHA4enpnU3lpZkpud1kwT2pNVGV4aXBrYnRzcExEdXFaZUhfTHBkSFFyWU9Uc090U2RtWUQxNDh6UVlRb20xN2lIRFNyNHFhenRoYVpJMjNsWmNRbEt3NFdiOEFUX1FYNFpCVkhjM1ljbTFFRHRTeC1JWUVuRUl5SGFwTnItb0lmX1daUFgtZzlFRVZ4SkE?oc=5) |
| Timothy Sykes | TCRT Stock Explodes Higher As Traders Chase Volatility | [Source Link](https://news.google.com/rss/articles/CBMiigFBVV95cUxNdGI5UGZRNFhHb2c1b0sxeWlmT3FJS2ZiYWxjcEVSQ2RRa3NDR2lMdEZyQXNLc1V4ZHdad0JaNGZmWjYwSFg4NDR4N05ETkdVNGo5M05QZno0ZWF5TnUzcU5jV1N5UTAxengxUDZHMGVjSUdBd1lxNTZFVm5UT0MwQ1VNc0lTbU9OYVE?oc=5) |
| Finimize | Three Small-Caps Put Big Numbers On The Tape Tuesday | [Source Link](https://news.google.com/rss/articles/CBMiiAFBVV95cUxPdGZlb2FVVEdsY09QaWpmcGtvNE84NUFCR2Z1MTU0YzUtcjI5dkIyWVFTYjFxazJmTlNTYXRudDFhc19nWkFIYnAwRTlyYTNzdGxmdERseWxtR0hWUzVPSm9CRjhnOUR4Tm50SVFuLXZtZm5KOHAzY3JXa0lwZHNTZDJUaDFuTk5Z?oc=5) |
| www.marketscreener.com | Alaunos Therapeutics, Inc. announced that it expects to receive $349.953008 million in funding | [Source Link](https://news.google.com/rss/articles/CBMi3AFBVV95cUxOZURsTkVuRzJIZmFKRnY0dE9LcmpNVHJSUjc4dmJtRks1VEhFdUh3U1lvZHNHQ241bGJIOGw2TUtOaUFnQlNKN0tjajBkdmRaUnpuSFFaNHFGempmSmhmeW5DXzItMmwxRFFfUS1wbzFtWkVFSFQwYmdrZVQ5bFllb0pCa1BwZjZwS2N2cmI5a3RfRXpGMzVUcGc1VU14eEViMmtsUGhwbFhaSW1LQlJpa0tfSXJEZVFzbjdSWGI4ajlIcEc4aFRYalFIN2hrOGRLblo0TnFpUWZzSzd4?oc=5) |
| Yahoo Finance | Top Midday Gainers | [Source Link](https://news.google.com/rss/articles/CBMiiwFBVV95cUxNYUdNTm51OWRxUV9GU051TWN6TGJHTGw3M3ZkNHAxc3RBc3RhVU1aLUZ6R19KVnQxOFhtaGpkaVVieTdtTmQzOW8wNkZvSDI3c01pa0psd215N1hLLUdfWEtSTk9BbXNlNlBtRmJRYk5nQjFzSzJibWo0Q2ZwSlZoS29SelFUb0JHYlF3?oc=5) |
| Investorideas.com | Biotech Stock Alaunos Therapeutics (NASDAQ: TCRT) Sees Triple Digit Gains on Acquisition and Funding | [Source Link](https://news.google.com/rss/articles/CBMi6wFBVV95cUxPSnJPODJoSVVlNldLWFBUOHZfZXVnVUlkemVic3hKVEdSUExxZlVJYTRyNzU4UkhCazh2cWVEWDFoWEJ1dXJXTXFOVks3bHBVYlRnSlZpZ1RNS2c3SXRDSko2WTVMUHBEX0dxVGg2Nl9WektwZU50d1JMamxCOS05YmFfWXVZTFh3b1pkZjNybFdQV1ZKTWVKVTl3dUl5Y3hKV2RCQWFvX0dtZFVMeUU1dFBBa2FOSzMwYV9WZmxzaDI0RmJVVFYyczJyejdaQWE2MjNSbzZ2VzF0N2ZVQkpDbkdMQkV3NzctX0Q4?oc=5) |
| Quiver Quantitative | Alaunos Therapeutics surges after Velaris acquisition and $350 million financing | [Source Link](https://news.google.com/rss/articles/CBMitgFBVV95cUxNb0Via2lTRERETHVuTUtFd09Rb2JELXl0cGI2bnhfU2I3VWtub3pVZnJCN0s4YlJUT0dLR3VBdHpNNTFjaURVUDg2RTlIYTZzeXFBcHNrUDBGTEtiUmtEYW1LTXRKaU5PQk5yYUVuOVF2OUctT1A4ZGE1WGNwWVNaMmJUU0tvb2d4NlVsYURfNy1NTGE1UXU2THJ1SFZ4S2RxZjl3N2plX1pKWnpBVzhRVmp6TFdRZw?oc=5) |
| StocksToTrade | TCRT Stock Rockets On Heavy Volume As Traders Pile In | [Source Link](https://news.google.com/rss/articles/CBMigwFBVV95cUxPXzdNWWJDa3BTak5NTXIyLW5HZEJ1RVFXaWQ5VTFidnY1LVFpVVVPWkY4bVluVnZlX1FvMjdfOXowaW9rSnZ6WENIUEJmMERGemZBam0xd2JRVkNNVEtib0U4ZWkzOXdZNWxZTmY0YmlEWnJPTHdQdGtUWGFSZDF5V3pLUQ?oc=5) |
| Investing.com | Paragon Labs adds former Apogee executives to leadership team | [Source Link](https://news.google.com/rss/articles/CBMiugFBVV95cUxPa1NmY0o5M0Q4V2dxcEhsMXlqSWhhQXJMMFdoeUFva1lNSVlpYUVMVU5zemE2ckRGcXRjM0dSUzB6c1lrVl9lRVZXLVlUbzNrOFZGSHF1Nm1pdDA3ZlIwU0xhdDlHRmM1bHl3Z2k5d0tjTHVmRG5udTlrM1pqeXNfZjNCQmtlbWdfWUo1eHk2SlE5aVJRYlgxdTNEcnJ2a1JFQkpzcXcwejV4QjNLdHh0WlBLakhfZ1ZNV0E?oc=5) |
| Benzinga | 12 Health Care Stocks Moving In Tuesday's Pre-Market Session | [Source Link](https://news.google.com/rss/articles/CBMiugFBVV95cUxOV1B5WU10NFBtZTFhYkFCNFhjYjJmR1NXLWlOdnVfTnJlSmpQT3Z4ZDNuaWFVRG53djhuenh2MHctdVdvTE40M24wR3RJdG9tbnJmU0p6TjdvcjVwY0ppVGduSzd3SWJtYlZHUk5pUHQyb1k4NFF1QVZNUDlVbE9jY1I3LVZIYXIxNi1lR2h2ZUlMaU5EcEs2d1NVNUl1RzdzMmhNTHlvazNJV3BkZDBxc1JvbEpoQTZ2Q1E?oc=5) |
| Investing.com Canada | Paragon Labs adds former Apogee executives to leadership team By Investing.com | [Source Link](https://news.google.com/rss/articles/CBMivwFBVV95cUxNQThIUE4tT3lPRVRDMFNHWEpkTFRpUmcyZlRXanYzdURWR1ZXWV9IeTN2U3M1R2RMdU5sSlYtalBheHB2M0djZW92N1NHQjc1b3Y5TEhyUjVzQkxKa3dOdlJuZ21EUXdkN1dvbnNEZ1pTVV9EdUF1dDV3Q244VGFxN29SVWZrV19KZ2lIengtME5EYWt2Y2tJTVpGY1VVZW5sMWNsRlVOcHY1MDBLQ3NlTVdMaFMySGcyZ1dHbW9GOA?oc=5) |
| TipRanks | Alaunos Acquires Velaris and Secures Major Financing | [Source Link](https://news.google.com/rss/articles/CBMipwFBVV95cUxOX1A1N0lMZFphdnJFTVF2NW1GR04tTUtLR0pua2xHUWhZZU9DZldaRmZheHNNdFk4cjJqenFQZlpQNktETExnR0E0MWNzbko4dV9ieEtjbnI2ZzQzUFhLalNWTWtMd19ZTlNNczd1U2QySDRneVhoYTlkTHR5bDR1ajBjNThtOERDOC0xNjg5QUxxVTU1RFJIcFZvLXY3VHZic0M4RGdYYw?oc=5) |
| PR Newswire | Paragon Labs Expands Leadership Team with Former Apogee Executives; Velaris Therapeutics Acquired by Alaunos Therapeutics, Inc. | [Source Link](https://news.google.com/rss/articles/CBMijAJBVV95cUxPZFhOQVFac0M5M1RoODF5U00xaTdsSWNzSWFLSEdvSnp4RGdpcVV3NVZMeHRVTV9aMVVobmNlM3UyVkFxYTc5NzZiWm9VbG02a3JrT00wV0VfQjZWMGVXNGhOZWlfb2ZhSzctb05XVEJKS3pPU0VTTF9Sb2hCSVRTcUYtRGp4TmNGbkFpQmlOZ1hxSXg1SjBDemVkUjY2Sk9hZ3lRcFVobWkyaTdmclAxdFJPTVdBdk5BVjVfWEdzbnhjNGhVcVpta3l2andxYVhQbl9fYUR0a3IwX1F4bDRwSWZvTHRmWmRoNGRGT2luOVByTHBJVktaQThyaUhRZmtfYlMwcWpFQUh3MEty?oc=5) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-10-13/after-10-9b-exit-to-abbvie-apogee-execs-join-paragon-to-scale-its-r-d-company*
